These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 9876602)
1. Investigations on the influence of the type of extruder for pelletization by extrusion-spheronization. I. Extrusion behavior of formulations. Thoma K; Ziegler I Drug Dev Ind Pharm; 1998 May; 24(5):401-11. PubMed ID: 9876602 [TBL] [Abstract][Full Text] [Related]
2. Investigations on the influence of the type of extruder for pelletization by extrusion-spheronization. II. Sphere characteristics. Thoma K; Ziegler I Drug Dev Ind Pharm; 1998 May; 24(5):413-22. PubMed ID: 9876603 [TBL] [Abstract][Full Text] [Related]
3. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption. Iosio T; Voinovich D; Grassi M; Pinto JF; Perissutti B; Zacchigna M; Quintavalle U; Serdoz F Eur J Pharm Biopharm; 2008 Jun; 69(2):686-97. PubMed ID: 18191390 [TBL] [Abstract][Full Text] [Related]
4. Extruder scale-up assessment in the process of extrusion-spheronization: comparison of radial and axial systems by a design of experiments approach. Désiré A; Paillard B; Bougaret J; Baron M; Couarraze G Drug Dev Ind Pharm; 2013 Feb; 39(2):176-85. PubMed ID: 23216219 [TBL] [Abstract][Full Text] [Related]
5. Upscaling and in-line process monitoring via spectroscopic techniques of ethylene vinyl acetate hot-melt extruded formulations. Almeida A; Saerens L; De Beer T; Remon JP; Vervaet C Int J Pharm; 2012 Dec; 439(1-2):223-9. PubMed ID: 23018111 [TBL] [Abstract][Full Text] [Related]
6. Use of extrusion aids for successful production of Kollidon Loka NC; Saripella KK; Pinto CA; Neau SH Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166 [TBL] [Abstract][Full Text] [Related]
7. Comparison between a twin-screw extruder and a rotary ring die press. Part II: influence of process variables. Schmidt C; Kleinebudde P Eur J Pharm Biopharm; 1998 Mar; 45(2):173-9. PubMed ID: 9704914 [TBL] [Abstract][Full Text] [Related]
8. The influence of plate design on the properties of pellets produced by extrusion and spheronization. Michie H; Podczeck F; Newton JM Int J Pharm; 2012 Sep; 434(1-2):175-82. PubMed ID: 22659150 [TBL] [Abstract][Full Text] [Related]
9. Rheological evaluation of wet masses for the preparation of pharmaceutical pellets by capillary and rotational rheometers. Majidi S; Motlagh GH; Bahramian B; Kaffashi B; Nojoumi SA; Haririan I Pharm Dev Technol; 2013 Feb; 18(1):112-20. PubMed ID: 22188436 [TBL] [Abstract][Full Text] [Related]
10. Comparison of two twin-screw extruders for continuous granulation. Djuric D; Van Melkebeke B; Kleinebudde P; Remon JP; Vervaet C Eur J Pharm Biopharm; 2009 Jan; 71(1):155-60. PubMed ID: 18678245 [TBL] [Abstract][Full Text] [Related]
11. The evaluation of formulations for the preparation of pellets with high drug loading by extrusion/spheronization. Podczeck F; Knight P Pharm Dev Technol; 2006; 11(3):263-74. PubMed ID: 16895837 [TBL] [Abstract][Full Text] [Related]
12. Drug solubility effects on predicting optimum conditions for extrusion and spheronization of pellets. Hileman GA; Upadrashta SM; Neau SH Pharm Dev Technol; 1997 Feb; 2(1):43-52. PubMed ID: 9552430 [TBL] [Abstract][Full Text] [Related]
13. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation. Chatchawalsaisin J; Podczeck F; Newton JM Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137 [TBL] [Abstract][Full Text] [Related]
14. Multiple batch manufacturing of theophylline pellets using the wet-extrusion/spheronization process with κ-carrageenan as pelletisation aid. Krueger C; Thommes M Pharm Dev Technol; 2013 Feb; 18(1):225-35. PubMed ID: 22780876 [TBL] [Abstract][Full Text] [Related]
15. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate. Chatchawalsaisin J; Podczeck F; Newton JM Eur J Pharm Sci; 2005 Jan; 24(1):35-48. PubMed ID: 15626576 [TBL] [Abstract][Full Text] [Related]
16. Production and characterization of pellets using Avicel CL611 as spheronization aid. Puah SY; Yap HN; Chaw CS Drug Dev Ind Pharm; 2014 Mar; 40(3):418-24. PubMed ID: 23480532 [TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of omeprazole pellets fabricated by sieving-spheronization and extrusion - spheronization process. Karim S; Baie SH; Hay YK; Bukhari NI Pak J Pharm Sci; 2014 May; 27(3):425-38. PubMed ID: 24811797 [TBL] [Abstract][Full Text] [Related]
18. Alginate-based pellets prepared by extrusion/spheronization: a preliminary study on the effect of additive in granulating liquid. Sriamornsak P; Nunthanid J; Luangtana-anan M; Puttipipatkhachorn S Eur J Pharm Biopharm; 2007 Aug; 67(1):227-35. PubMed ID: 17276664 [TBL] [Abstract][Full Text] [Related]
19. Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristics. Iyer RM; Augsburger LL; Pope DG; Shah RD Pharm Dev Technol; 1996 Dec; 1(4):325-31. PubMed ID: 9552316 [TBL] [Abstract][Full Text] [Related]
20. The influence of the extrusion die on pellet characteristics. Rabisková M; Weingartová D; Häring A Ceska Slov Farm; 2007 Jan; 56(1):17-20. PubMed ID: 17432277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]